Stuart Goodman, MD, PhD

Arthritis and joint replacement surgeon, Orthopaedic surgeon, Total joint replacement surgeon

Bio:   Brief Biography: Stuart B. Goodman MD MSc PhD FRCSC FACS FBSE
Stuart B. Goodman is the Robert L. and Mary Ellenburg Professor of Surgery, and Professor with Tenure in the Department of Orthopaedic Surgery at Stanford University. He has a courtesy appointment in the Department of Bioengineering, and is a Fellow of the Institute of Chemistry, Engineering and Medicine for Human Health (ChEM-H) at Stanford University. He was Chief of Orthopaedic Surgery at Stanford University from 1994-2002. Dr. Goodman received his BSc, MD and MSc (Institute of Medical Science) from the University of Toronto, and his PhD in Orthopedic Medical Science from Lund University in Sweden. He is a Fellow of the Royal College of Surgeons (Canada), the American Academy of Orthopaedic Surgeons and the American College of Surgeons. Dr. Goodman's clinical practice concentrates on adult reconstructive surgery. His clinical research interests center on the outcome of surgery for arthritis including primary and revision total joint replacement, juvenile arthritis, and osteonecrosis of the hip and knee. His basic science interests center on biocompatibility of orthopaedic implants, inflammation, and musculoskeletal tissue regeneration and repair. Dr. Goodman is/has been a member of numerous academic organizations including the AAOS Biological Implants Committee (Chairman), and is a former member of the AAOS Biomedical Engineering Committee. He is a member of the Hip Society, Knee Society and AAHKS, a consultant to the Orthopaedic and Rehabilitation Devices Advisory Panel of the FDA, and former vice-chairman of the Musculoskeletal Tissue Engineering study section at NIH. Dr. Goodman is on the editorial board of the Journal of Orthopaedic Research (Associate Editor), Clinical Orthopaedics (Associate Editor), Biomaterials (Associate Editor), Journal of Arthroplasty, Journal of Biomedical Materials Research, and other journals, and is a manuscript reviewer for over 30 journals in the fields of orthopaedic surgery, arthritis, bioengineering and biomaterials. Dr. Goodman has published over 500 peer-reviewed manuscripts in medical and bioengineering journals. Dr. Goodman and co-workers have received awards for their research from the Society for Biomaterials, Orthopaedic Research Society, the American Orthopaedic Association, Western Orthopaedic Association, and the Association of Bone and Joint Surgeons. Dr. Goodman was awarded the Clemson Award for Basic Research from the Society For Biomaterials in May 2000. He was the President of the Society For Biomaterials (2001-2) and served on the Board of Directors of the Orthopaedic Research Society. Dr. Goodman served as Co-Chair for the 1995, 2000 and 2007 NIH/AAOS-sponsored workshops on Implant Wear. Dr. Goodman was recognized as a Fellow, Biomaterials Science and Engineering (FBSE) by the International Union of Societies, Biomaterials Science and Engineering in May 2004, a Fellow of the Japanese Society of the Promotion of Science in 2011, and a Fellow of the American Institute of Medical and Biological Engineers in 2012.

Dr. Goodman serves as a consultant for several companies including Hyalex,, Accelalox, Pluristem, and Wishbone Medical.

Arthritis and Joint Replacement Service

Orthopaedics and Sports Medicine in Redwood City

Professional Education

  • Residency: University of Toronto (1984)
  • Medical Education: University of Toronto (1978) Canada
  • Internship: Toronto General Hospital Postgraduate Education (1979) Canada
  • Board Certification: American Board of Orthopaedic Surgery, Orthopaedic Surgery (1987)
  • Fellowship: Sunnybrook Medical Center (1985) Canada
  • Fellowship: Wellesley Hospital (1985) Canada

Honors & Awards

  • America's Most Honored Professionals, America's Most Honored Professionals (2016-2020)
  • America's Top Doctors, America's Top Doctors (2000-2020)
  • America's Top Surgeons, America's Top Surgeons (2016-2020)
  • Clemson Award for Basic Research, Society For Biomaterials., Society For Biomaterials (2000)
  • Compassionate Doctor Award, Compassionate Doctor Award (2015, 2020)
  • Fellow, American Institute of Medical and Biological Engineers (2012)
  • Fellow, International Combined Orthopaedic Research Societies (2016)
  • Fellow, Japan Society for the Promotion of Science (2011)
  • Fellow, Biomaterials Science and Engineering (FBSE), International Union of Societies, Biomaterials Science and Engineering (2004)
  • Patient's Choice Award, Patient's Choice Award (2012-2015, 2020)
  • Patriotic Employer Award, Employer Support of the Guard and Reserve (ESGR), Department of Defense (2018)
  • Saul Halpern M.D. Orthopaedic Educator Award, Department of Orthopaedic Surgery, Stanford University (2007)

Administrative Appointments

  • Affiliated Faculty – Stanford Center on Longevity, Stanford University (2005 - Present)
  • Associated Faculty - Biomechanical Engineering Program, Mechanical Engineering Department, Stanford University (1990 - Present)
  • Fellow, Institute for Chemistry, Engineering and Medicine for Human Health (ChEM-H),, Stanford University (2014 - Present)
  • Fellowship Director, Orthopaedic Adult Reconstruction, Stanford University (2008 - Present)
  • Professor, Orthopaedic Surgery, Stanford University (2002 - Present)
  • Professor (by courtesy), Department of Bioengineering, Stanford University (2011 - Present)
  • Robert and Mary Ellenburg Professor of Surgery, Stanford University (2006 - Present)

Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.

Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.